Wolfe Research analyst issues OUTPERFORM recommendation for MU on September 23, 2026 04:18PM ET. The previous analyst recommendation was Outperform.MU was trading at $1066.09 at issue of the analyst recommendation.The overall analyst consensus : BUY.Current analyst recommendations are : 58 - Buy, 10 - Hold, 2 - Sell recommendations .Historical Analyst RecommendationsLatest 10 recommendationsReport DateAnalyst...
The surge in artificial intelligence (AI) development has transformed numerous industries, drawing significant attention from tech...
Monetizing artificial intelligence (AI) stands as a crucial endeavor in today’s technology landscape, with far-reaching implications...
In a surprising turn of events on Wednesday morning, shares of Palantir Technologies (NASDAQ: PLTR) saw...
from Oppenheimer issued a price target of $52.00 for NKE on 2026-09-23 12:45:29.The adjusted price target...
from Oppenheimer issued a price target of $52.00 for NKE on 2026-09-23 12:45:29.The adjusted price target was set to $52.00.At the time of the announcement, NKE was trading at $35.9.The...
from Truist Financial issued a price target of $31.00 for RF on 2026-09-23 11:56:50.The adjusted price target was set to $31.00.At the time of the announcement, RF was trading at...
from Truist Financial issued a price target of $63.00 for FITB on 2026-09-23 11:55:47.The adjusted price target was set to $63.00.At the time of the announcement, FITB was trading at...
from Truist Financial issued a price target of $19.00 for HBAN on 2026-09-23 11:54:51.The adjusted price target was set to $19.00.At the time of the announcement, HBAN was trading at...
from UBS issued a price target of $23.00 for PBR on 2026-09-23 11:35:47.The adjusted price target was set to $23.00.At the time of the announcement, PBR was trading at $20.76.The...
In the first quarter of 2025, the company faced revenue declines, largely due to Paxlovid, while operational expenses surged. Management is committed to enhancing R&D productivity and optimizing capital allocation,...
In a landscape of fluctuating markets and regulatory uncertainties, the company experienced a remarkable revenue surge, reaching $36,077 million. Despite operational challenges, net income stood at $7,713 million. Management emphasized...
In the bustling corridors of Merck, management reflects on a transformative quarter. With net income rising to 5,085 million, the company celebrates strategic wins in oncology and diabetes, driven by...
In 2025, the company embraced growth through increased research and development, despite rising operating expenses. A net income of $24,780 million marked a decline, reflecting challenges in a fluctuating market....
In the first quarter of 2025, the company experienced a 9% revenue growth, fueled by increased sales and services. Operating expenses rose, reflecting evolving cost structures, while net income showed...
In recent developments within the financial markets, Amazon.com, Inc. (NASDAQ: AMZN) has emerged as a prime focus for several notable institutional investors and financial analysts, signaling a renewed confidence in...
In recent weeks, personal AI assistants have significantly advanced beyond their traditional roles of merely responding to inquiries; they are now increasingly tasked with carrying out everyday activities. A prominent...
In recent months, several institutional investors have significantly increased their holdings in Microsoft Corporation (NASDAQ: MSFT), reflecting a growing confidence in the tech giant as demand for artificial intelligence (AI)...
Michael Burry, the famed investor best known for his role in predicting the subprime mortgage crisis, has made headlines once again as he announces a new round of portfolio changes....
In a turbulent period for investors, Space Exploration Technologies Corp. (commonly known as SpaceX) went public in June, but its stock has since dropped dramatically, losing nearly one-third of its...
